INR 393.0
(-0.57%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 5.47 Billion INR | -18.79% |
2022 | 6.74 Billion INR | -7.73% |
2021 | 7.31 Billion INR | 3.34% |
2020 | 7.07 Billion INR | 12.48% |
2019 | 6.29 Billion INR | 11.17% |
2018 | 5.65 Billion INR | 43.2% |
2017 | 3.95 Billion INR | 26.79% |
2016 | 3.11 Billion INR | 7.36% |
2015 | 2.9 Billion INR | 10.72% |
2014 | 2.62 Billion INR | 1.36% |
2013 | 2.58 Billion INR | 14.59% |
2012 | 2.25 Billion INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 FY | 5.92 Billion INR | -12.24% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 5.94 Billion INR | 0.0% |
2023 Q4 | 5.47 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 7.07 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 6.71 Billion INR | 0.0% |
2022 FY | 6.74 Billion INR | -7.73% |
2021 FY | 7.31 Billion INR | 3.34% |
2021 Q4 | 7.31 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 6.89 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 Q4 | 7.07 Billion INR | 0.0% |
2020 FY | 7.07 Billion INR | 12.48% |
2020 Q1 | - INR | -100.0% |
2020 Q2 | 6.81 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 Q1 | - INR | -100.0% |
2019 FY | 6.29 Billion INR | 11.17% |
2019 Q2 | 6.3 Billion INR | 0.0% |
2019 Q4 | 6.13 Billion INR | 0.0% |
2018 Q4 | 5.51 Billion INR | 0.0% |
2018 FY | 5.65 Billion INR | 43.2% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 5.05 Billion INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 Q2 | 3.24 Billion INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q4 | 3.84 Billion INR | 0.0% |
2017 FY | 3.95 Billion INR | 26.79% |
2017 Q1 | - INR | -100.0% |
2016 FY | 3.11 Billion INR | 7.36% |
2016 Q4 | 3.07 Billion INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 Q2 | 3.04 Billion INR | 0.0% |
2015 Q2 | 2.82 Billion INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2015 FY | 2.9 Billion INR | 10.72% |
2015 Q4 | 2.88 Billion INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2014 Q2 | 2.47 Billion INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2014 FY | 2.62 Billion INR | 1.36% |
2014 Q4 | 2.62 Billion INR | 0.0% |
2013 FY | 2.58 Billion INR | 14.59% |
2013 Q3 | - INR | -100.0% |
2013 Q4 | 2.58 Billion INR | 0.0% |
2013 Q2 | 2.21 Billion INR | 0.0% |
2012 Q3 | - INR | 0.0% |
2012 FY | 2.25 Billion INR | 0.0% |
2012 Q4 | 2.25 Billion INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Alfavision Overseas (India) Limited | 1.78 Billion INR | -206.802% |
Biocon Limited | 560.7 Billion INR | 99.023% |
Blue Jet Healthcare Limited | 10.58 Billion INR | 48.262% |
Concord Biotech Limited | 17 Billion INR | 67.788% |
Dishman Carbogen Amcis Limited | 95.81 Billion INR | 94.282% |
GENOMIC VALLEY BIOTECH LIMITED | 43.33 Million INR | -12541.26% |
Lyka Labs Limited | 1.56 Billion INR | -249.551% |
Panacea Biotec Limited | 12.4 Billion INR | 55.844% |
SAMSRITA LABS LIMITED | 155.51 Million INR | -3422.733% |
Servoteach Industries Limited | 1591.00 INR | -344331012.508% |
SMS Lifesciences India Limited | 3.9 Billion INR | -40.283% |
Supriya Lifescience Limited | 9.21 Billion INR | 40.533% |
Syngene International Limited | 61.51 Billion INR | 91.094% |
TAKE Solutions Limited | 881.05 Million INR | -521.793% |
Titan Biotech Limited | 1.56 Billion INR | -249.873% |
Transgene Biotek Limited | 324.4 Million INR | -1588.735% |
Vanta Bioscience Limited | 853.96 Million INR | -541.514% |